Overview
Dr. Paul Harmatz is a Pediatric Gastroenterologist who specializes in mucopolysaccharidoses (MPS) and other lysosomal storage diseases. He is the Medical Director of the Pediatric Clinical Research Program in Mucopolysaccharidoses (MPS) and Related Disorders at UCSF Benioff Children's Hospital. Dr. Harmatz has been the Principal Investigator on multiple clinical trials involving MPS and its variants. He is licensed to practice in CA.
Dr. Harmatz is rated as an Experienced provider by MediFind in the treatment of Pompe Disease. His top areas of expertise are Mucopolysaccharidoses (MPS), Mucopolysaccharidosis Type 6 (MPS VI, Maroteaux-Lamy Syndrome), Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), and Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome).
His clinical research consists of co-authoring 164 peer reviewed articles and participating in 22 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Pompe Disease.
Insurance
Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.
Accepted insurance plans
- Humana
Locations
744 52nd St, 5th Floor, Oakland, CA 94609
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
22 Clinical Trials
Areas of Expertise
When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
To learn more about how MediFind determines the expertise levels, check out our expert tiers page.
- Elite
- Mucopolysaccharidoses (MPS)
- Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)
- Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome)
- Mucopolysaccharidosis Type 6 (MPS VI, Maroteaux-Lamy Syndrome)
- Distinguished
- Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome)
- Mucopolysaccharidosis Type 3 (MPS III, Sanfilippo Syndrome)
- Mucopolysaccharidosis Type 3B (MPS IIIB, Sanfilippo Syndrome B)
- Mucopolysaccharidosis Type 4A (MPS IVA, Morquio Syndrome Type A)
- Mucopolysaccharidosis Type 7 (MPS VII, Sly Syndrome)
- Experienced
- Anemia
- Enlarged Liver
- Fabry Disease
- Gaucher Disease Type 2
- Gaucher Disease Type 3
- Mucopolysaccharidosis Type 3A (MPS IIIA, Sanfilippo Syndrome A)